Population Pharmacokinetics of Intermittent Vancomycin in Children with Cystic Fibrosis-Reference-Cited by-同舟云学术

Population Pharmacokinetics of Intermittent Vancomycin in Children with Cystic Fibrosis

Published:2013-07-03 Issue:12 Volume:33 Page:1288-1296
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Stockmann Chris¹²,Sherwin Catherine M. T.¹²,Zobell Jeffery T.³⁴,Lubsch Lisa⁵,Young David C.⁶⁷,Olson Jared¹³,Noyes Blakeslee E.⁸⁹,Ampofo Krow¹,Spigarelli Michael G.¹²

Affiliation:

1. Department of Pediatrics; University of Utah School of Medicine; Salt Lake City Utah

2. Department of Pharmacology and Toxicology; University of Utah College of Pharmacy; Salt Lake City Utah

3. Department of Pharmacy; Intermountain Primary Children's Medical Center; Salt Lake City Utah

4. Intermountain Cystic Fibrosis Pediatric Center; Salt Lake City Utah

5. School of Pharmacy; Southern Illinois University Edwardsville; Edwardsville Illinois

6. Intermountain Cystic Fibrosis Adult Center; Salt Lake City Utah

7. University of Utah College of Pharmacy; Salt Lake City Utah

8. Department of Pediatrics; St. Louis University School of Medicine; St. Louis Missouri

9. SSM Cardinal Glennon Children's Medical Center; St. Louis Missouri

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1320/fullpdf

Reference46 articles.

1. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists;Rybak;Am J Health Syst Pharm,2009

2. The role of screening and antibiotic prophylaxis in the prevention of percutaneous gastrostomy site infection caused by methicillin-resistant Staphylococcus aureus;Thomas;Aliment Pharmacol Ther,2007

3. Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: an eradication protocol;Solis;Pediatr Pulmonol,2003

4. Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis;Miall;Arch Dis Child,2001

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics and target attainment analysis of vancomycin after intermittent dosing in adults with cystic fibrosis;Antimicrobial Agents and Chemotherapy;2024-01-10

2. Population Pharmacokinetics and Target Attainment Analysis of Vancomycin after Intermittent Dosing in Adults with Cystic Fibrosis;2023-08-01

3. Pharmacokinetic and Pharmacodynamic Basis of Optimal Antimicrobial Therapy;Principles and Practice of Pediatric Infectious Diseases;2023

4. Implementation of a Pharmacist-Driven Vancomycin and Aminoglycoside Dosing Service in a Pediatric Hospital;The Journal of Pediatric Pharmacology and Therapeutics;2022-04-01

5. Establishment and application of population pharmacokinetics model of vancomycin in infants with meningitis;Pediatrics & Neonatology;2022-01